[{"NetIncomeLoss_1_Q1_USD":-3526000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingLeaseRightOfUseAsset_0_Q1_USD":274000.0,"ShareBasedCompensation_1_Q1_USD":250000.0,"Assets_0_Q1_USD":284050000.0,"CommonStockSharesIssued_0_Q1_shares":40008654.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":107000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1746000.0,"AssetsCurrent_0_Q1_USD":283766000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":36000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":1553000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"InterestAndOtherIncome_1_Q1_USD":7000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":37721000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":1004000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"OperatingLeaseLiability_0_Q1_USD":297000.0,"Liabilities_0_Q1_USD":2863000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":213000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":282192000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-47000.0,"OtherAssetsCurrent_0_Q1_USD":1574000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":190992000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":16000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":-185000.0,"CommonStockValue_0_Q1_USD":40000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":834000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":189825000.0,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":-44000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":10000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"SharesIssued_0_Q1_shares":4081633.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":135015.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":281187000.0,"AdditionalPaidInCapital_0_Q1_USD":459594000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":475000.0,"OtherCommitment_0_Q1_USD":817000.0,"AccountsPayableCurrent_0_Q1_USD":864000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":188686000.0,"LiabilitiesCurrent_0_Q1_USD":2650000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":102000.0,"ProceedsFromWarrantExercises_1_Q1_USD":692000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":311000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-2306000.0,"CommonStockSharesOutstanding_0_Q1_shares":40008654.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-178447000.0,"StockholdersEquity_0_Q1_USD":281187000.0,"OtherLiabilitiesCurrent_0_Q1_USD":50000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.09,"OperatingExpenses_1_Q1_USD":3533000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":84000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":250000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":99000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":284050000.0,"PreferredStockValue_0_Q1_USD":null,"OperatingIncomeLoss_1_Q1_USD":-3533000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":null,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":66000.0,"Ticker":"SAVA","CIK":"1069530","name":"CASSAVA SCIENCES INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210429"}]